Notable Labs, Ltd.
NTBLQ
$0.00
$0.000.00%
OTC PK
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | 2,250.00% | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | 2,250.00% | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | 175.00% | -- | -- |
SG&A Expenses | 56.73% | -41.65% | 185.89% | 10.90% | 52.85% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 80.24% | -30.44% | 79.30% | -15.06% | -21.21% |
Operating Income | -80.17% | 30.46% | -72.49% | 20.60% | 21.21% |
Income Before Tax | -51.94% | 39.96% | 22.23% | 238.29% | 0.84% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -51.94% | 39.96% | 22.23% | 238.29% | 0.84% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -51.94% | 39.96% | 22.23% | 238.29% | 0.84% |
EBIT | -80.17% | 30.46% | -72.49% | 20.60% | 21.21% |
EBITDA | -81.81% | 30.75% | -74.01% | 20.27% | 21.04% |
EPS Basic | 84.41% | 93.54% | -32.99% | 238.27% | -488.40% |
Normalized Basic EPS | 84.41% | 93.54% | -32.99% | 238.21% | -488.40% |
EPS Diluted | 84.41% | 93.54% | -32.99% | 238.27% | -488.40% |
Normalized Diluted EPS | 84.41% | 93.54% | -32.99% | 238.21% | -488.40% |
Average Basic Shares Outstanding | 874.42% | 829.53% | -41.53% | 0.03% | -83.15% |
Average Diluted Shares Outstanding | 874.42% | 829.53% | -41.53% | 0.03% | -83.15% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |